The Biotic company obtains European financing to market the online legionella detection system
The biotechnology company Biotic Biochemistry Analytic SL located in the Scientific, Technological and Business Park of the Universitat Jaume I of Castellón (espaitec) has been one of the 14 Spanish companies that have accessed financing from the H2020 SME Instrument, which will invest in this second phase 73 million euros in 47 innovative SMEs.
Biotics It is the only company in the European biotechnology sector that has made the cut. Its objective is to develop and market an online detection and quantification system of Legionella spp in water (ULISENS). The firm is specialized in the development of rapid tests for the detection of pathogens in environmental samples with several products on the market, focused on the detection of Legionella, such as Legipid®Legionella Fast Detection.
The overall objective of the ULISENS (Ultra Legionella Immunoanalysis System for Early Sensing) project is to develop and subsequently market an automatic alert system capable of detecting and quantifying Legionella in water. The completely new system includes a rapid automatic detection module capable of carrying out real-time analysis on-site using information and communication technologies to minimise the time required to obtain results. This system is completely innovative as there is no technology on the market capable of carrying out an automated on-site analysis of Legionella present in an installation.
The European Commission has received 553 proposals to access the second phase, of which around 10% have been selected. Among all the selected projects, the Spanish ones stand out, with 14 SMEs of the 47 selected in fourteen countries that will receive a total of 15,4 million euros. Each project will receive up to 2,5 million euros (5 million in the case of health projects) to finance innovation, testing, piloting, scale-up and miniaturization activities, in addition to developing a mature business plan for its product.


